Benign neoplasm: Eye, unspecified (controls excluding all cancers)

CD2_EYE_NOS_EXALLC

No definition available.

Endpoint definition

↥

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D31.9&

Hospital discharge: ICD-9 224[8-9]|2240

Hospital discharge: ICD-8 22409|22402

Cause of death: ICD-10 D31.9&

Cause of death: ICD-9 224[8-9]|2240

Cause of death: ICD-8 22409|22402

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

113

diagram downward connector

CD2_EYE_NOS_EXALLC

Control definitions

Control exclude C3_CANCER

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D31

Name in latin Neoplasma benignum oculi non specificatum

NAME	CD2_EYE_NOS_EXALLC
CONTROL_EXCLUDE	C3_CANCER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D319
HD_ICD_9	224[8-9]\|2240
HD_ICD_8	22409\|22402
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D319
COD_ICD_9	224[8-9]\|2240
COD_ICD_8	22409\|22402
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Eye, unspecified (controls excluding all cancers) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Benign neoplasm: Eye, unspecified

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	113	72	41
Unadjusted prevalence (%)	0.03	0.03	0.02
Mean age at first event (years)	55.19	53.72	57.77

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_EYE_NOS_EXALLC – Benign neoplasm: Eye, unspecified (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Benign neoplasm: Eye, unspecified (controls excluding all cancers)
after Benign neoplasm: Eye, unspecified (controls excluding all cancers)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Benign neoplasm: Eye, unspecified (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.